Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus
Clinical trial NCT06881290 · RECRUITING
Trial details
- NCT number
- NCT06881290
- Sponsor
- Chinese SLE Treatment And Research Group
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-19
- Primary completion
- 2026-11-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.